Semaglutide, sold in the forms of Ozempic and Wegovy, shot into public consciousness as an effective weight-loss medication last year, thanks to spruiking from social media influencers and people such as Elon Musk.
The unexpected increased in demand for the drug for weight loss has caused a world-wide shortage. Producing the drug – delivered as a weekly self-administered injection – involves a unique manufacturing set-up, so it will take some time to re-establish a global supply. It’s expected back in Australia at the end of March.
